These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16908515)

  • 1. Slamming the door on unwanted guests: why preemptive strikes at the mucosa may be the best strategy against HIV.
    Trapp S; Turville SG; Robbiani M
    J Leukoc Biol; 2006 Nov; 80(5):1076-83. PubMed ID: 16908515
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
    Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
    J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
    Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G
    Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beast in the belly. A new focus on early HIV infection in the gut and other mucosal tissues may generate novel strategies to study, treat, and prevent infection.
    Cohen P
    IAVI Rep; 2006; 10(2):1-5. PubMed ID: 16721993
    [No Abstract]   [Full Text] [Related]  

  • 6. Variability in early HIV-1 population dynamics.
    Le Corfec E; Tuckwell HC
    AIDS; 1998 May; 12(8):960-2. PubMed ID: 9631156
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk.
    Petitjean G; Becquart P; Tuaillon E; Al Tabaa Y; Valea D; Huguet MF; Meda N; Van de Perre P; Vendrell JP
    J Clin Virol; 2007 May; 39(1):1-8. PubMed ID: 17387039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A primer on HIV/AIDS.
    JCN
    J Christ Nurs; 2007; 24(1):14-6; quiz 17-8. PubMed ID: 17283817
    [No Abstract]   [Full Text] [Related]  

  • 10. Cervical findings may alter microbicide development.
    AIDS Alert; 1997 Apr; 12(4):42-3. PubMed ID: 11364146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-infection of CD4+ T-cells enhances their effectiveness against hepatocytes infected with malaria parasites.
    Parris GE
    Med Hypotheses; 2007; 68(5):1187-8. PubMed ID: 17098375
    [No Abstract]   [Full Text] [Related]  

  • 14. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV diterpenes from Coleus forskohlii.
    Bodiwala HS; Sabde S; Mitra D; Bhutani KK; Singh IP
    Nat Prod Commun; 2009 Sep; 4(9):1173-5. PubMed ID: 19831022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions.
    Tjomsland V; Ellegård R; Kjölhede P; Wodlin NB; Hinkula J; Lifson JD; Larsson M
    Eur J Immunol; 2013 Sep; 43(9):2361-72. PubMed ID: 23686382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major CD4 epitopes involved in anti-CD4 T-cell autoimmunity in HIV-1 patients.
    Abulafia-Lapid R; Keren-Zur Y; Yachnin Y; Atlan H
    Vaccine; 2007 Apr; 25(16):3192-9. PubMed ID: 17298856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccines against HIV].
    Holm-Hansen C
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.